Document Detail


Correlation between insulin requirements and anti-galactose antibodies in patients with type 1 diabetes transplanted with neonatal pig islets.
MedLine Citation:
PMID:  21501149     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Pig xenografts represent an alternative source of organs for transplantation. Immunosuppression can prevent rejection, but involves high risk and cost. New anti-rejection techniques have been developed; however, results have not been successful. Few studies have reported xenoantibody levels in xenotransplanted patients with diabetes and no patients have reported a clinical correlation. We analysed anti-galactose (Gal) and other anti-pig antibody (APA) levels in xenotransplanted patients with type 1 diabetes and the relation to the clinical outcome. Twenty-three patients with type 1 diabetes were transplanted with porcine islets inside a device without immunosuppression. Demographic characteristics, insulin dose and xenoantibody levels at different periods were recorded. Anti-Gal and anti-pig antibodies were measured through indirect enzyme-linked immunosorbent assay (ELISA) and haemolytic anti-pig antibody assay. More than 50% were female; the mean current age, current diabetes duration, diabetes duration at xenotransplantation and time post-transplantation were: 20·8, 11, 5·5 and 5·7 years, respectively. Insulin doses remained with a mean reduction greater than 33% in more than 50% of the patients. The lowest anti-Gal antibody levels were related to the highest insulin dose reductions. This relationship could be explained by the device, Sertoli cells and accommodation process.
Authors:
R Esquivel-Pérez; A L Rodriguez-Ventura; L M Dorantes; B Ramírez-González; M G López-Santos; R Valdes-Gonzalez
Related Documents :
18776159 - Histopathology of the urinary bladders of cynomolgus monkeys treated with ppar agonists.
15235149 - Hypoglycemic activity of inorganic constituents in eugenia jambolana seed on streptozot...
15114029 - Individualized risk management in diabetics: how to implement best practice guidelines-...
16775469 - "working hard with it": self-management of type 2 diabetes by rural african americans.
18927259 - Equivalence of earlobe site blood glucose testing with finger stick.
16311649 - Reappraisal of the management of cholelithiasis in diabetics.
11217019 - Monitoring of recombinant human insulin production by narrow-bore reversed-phase high-p...
6283579 - Absence of naloxone sensitivity in obese humans.
18787059 - Differential impact of adipokines derived from primary adipocytes of wild-type versus s...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-4-19
Journal Detail:
Title:  Clinical and experimental immunology     Volume:  -     ISSN:  1365-2249     ISO Abbreviation:  -     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-4-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0057202     Medline TA:  Clin Exp Immunol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2011 The Authors. Clinical and Experimental Immunology © 2011 British Society for Immunology.
Affiliation:
Cell Therapy Laboratory Endocrinology Department, Mexico Children's Hospital Federico Gomez Surgery Department, Medicine School, National Autonomous University of Mexico (UNAM), Mexico.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Blocking induction of T helper type 2 responses prevents development of disease in a model of childh...
Next Document:  Effects of oestradiol and raloxifene on the induction and effector phases of experimental postmenopa...